Adding oxidative stress to FLT3 inhibition proves promising combination against AML
FLT3 inhibitors are a promising new class of drugs targeting acute myeloid leukemia (AML). However, these inhibitors alone tend not to result in long-term control of the disease. A University of Colorado Cancer Center study ...
Oct 11, 2016
1
0